Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 484,830 | 332,510 | 189,900 | 46,190 | 360,850 |
| Depreciation Amortization | 15,790 | 11,930 | 7,980 | 3,960 | 16,560 |
| Income taxes - deferred | -70,387 | N/A | N/A | N/A | -23,708 |
| Accounts receivable | -88,783 | N/A | N/A | N/A | -21,312 |
| Accounts payable and accrued liabilities | -542 | N/A | N/A | N/A | 1,804 |
| Other Working Capital | N/A | N/A | -102,140 | -15,600 | 60,060 |
| Other Operating Activity | 65,872 | -151,600 | 410 | 1,180 | -36,614 |
| Operating Cash Flow | $406,780 | $192,840 | $96,150 | $35,730 | $357,640 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -43,205 | N/A | N/A | N/A | -113,545 |
| PPE Investments | -19,990 | -14,010 | -10,460 | -5,980 | -21,240 |
| Purchase Of Investment | 2,112 | N/A | N/A | N/A | -33,956 |
| Purchase Sale Intangibles | -158 | N/A | N/A | N/A | -4,555 |
| Other Investing Activity | -30,997 | -91,020 | -34,470 | 75,370 | -4,549 |
| Investing Cash Flow | $-92,080 | $-105,030 | $-44,930 | $69,390 | $-173,290 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -10,944 | N/A | N/A | N/A | -11,874 |
| Common Stock Issued | 26 | N/A | N/A | N/A | 1,262 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -192,999 |
| Other Financing Activity | 8 | -10,690 | -390 | -190 | 151 |
| Financing Cash Flow | $-10,910 | $-10,690 | $-390 | $-190 | $-203,460 |
| Exchange Rate Effect | -32,110 | -3,850 | -2,170 | 2,970 | -8,200 |
| Beginning Cash Position | 209,960 | 209,960 | 209,960 | 209,960 | 237,280 |
| End Cash Position | 481,640 | 283,210 | 258,610 | 317,870 | 209,960 |
| Net Cash Flow | $271,670 | $73,250 | $48,640 | $107,900 | $-27,310 |
| Free Cash Flow | |||||
| Operating Cash Flow | 406,780 | 192,840 | 96,150 | 35,730 | 357,640 |
| Capital Expenditure | -19,997 | N/A | N/A | N/A | -21,249 |
| Free Cash Flow | 386,783 | 192,840 | 96,150 | 35,730 | 336,391 |